CompanyDeals

Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing

CompanyDrug

CARsgen Therapeutics’ CT0596 Receives NMPA Clinical Approval for Relapsed/Refractory Multiple Myeloma

CompanyDrug

InnoCare Pharma’s Orelabrutinib-Mesutoclax Combination Receives Breakthrough Therapy Designation for Marginal Zone Lymphoma

CompanyDrug

Adlai Nortye’s AN4035 Receives Australian Regulatory Approvals for First-in-Class Pan-RAS(ON) ADC

CompanyDrug

Zai Lab’s Zocilurtatug Pelitecan Receives FDA Orphan Drug Designation for Neuroendocrine Carcinoma

Drug

FDA Grants Biologics License to Ezplaz Freeze-Dried Plasma, First FDP Approved in United States

CompanyDrug

Novartis’ Pluvicto Receives FDA Approval for Metastatic Hormone-Sensitive Prostate Cancer

HutchMed Reports H1 2026 Results with Strong Oncology Growth Despite Overall Revenue Decline
Company

HutchMed Reports H1 2026 Results with Strong Oncology Growth Despite Overall Revenue Decline

CompanyDeals

Siemens Healthineers and Cleveland Clinic Announce 10-Year Strategic Partnership

CompanyDeals

Apeloa Pharmaceutical and METiS Therapeutics Announce Strategic CDMO Partnership

CompanyMedical Device

Sansure Biotech Secures EU IVDR CE Certification for Five Nucleic Acid Diagnostic Kits

CompanyDrug

Sino Biopharmaceutical’s TQB2102 Receives Breakthrough Therapy Designation from NMPA for HER2-Low Breast Cancer